Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/07/20
End: 08/23/22
Due: 08/23/23
Phase: N/A
Priority: Normal
Start: 06/07/23
End: 06/30/25
Due: 06/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism | NCT05239221 | Amolyt Pharma | user2@example.com | None | 2020-09-07 | 2022-08-23 | 2023-08-23 | - | - | 2025-07-14 |
| Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism | NCT05778071 | Amolyt Pharma | user2@example.com | None | 2023-06-07 | 2025-06-30 | 2026-06-30 | - | - | 2025-07-14 |